Internal Medicine News - Oral solution levaquin approved
Levaquin (levofloxacin) oral solution 25 mg/mL is indicated for the treatment of acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, nosocomial pneumonia, community-acquired pneumonia, complicated and uncomplicated skin infections, chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections, and acute pyelonephritis.
Related Results
Levaquin approvalLevaquin doseNew indication for LevaquinLevaquin tablets and oral solutionShort-course Levaquin approved
For more information, contact Ortho-McNeil Pharmaceutical Inc. by calling 800-682-6532 or visiting www.levaquin.com.
COPYRIGHT 2004 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
